HOWL CIK: 1785530

Werewolf Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−50.1
FY22:
−56.1
FY23:
−40.5
FY24:
−73.6
FY25:
−60.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−49.9
FY22:
−52.7
FY23:
−32.5
FY24:
−63.5
FY25:
−53.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−50.0
FY22:
−53.8
FY23:
−37.4
FY24:
−70.5
FY25:
−60.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−50.0
FY22:
−53.8
FY23:
−37.4
FY24:
−70.5
FY25:
−60.8

All amounts in millions USD Data sources:SEC EDGARTwelve Data